Zenobia lands spot on Alzheimer's Foundation consultant list
This article was originally published in Scrip
Executive Summary
Zenobia Therapeutics became one of several biotechnology companies offering discounted services and drug discovery expertise to researchers affiliated with the non-profit Alzheimer's Drug Discovery Foundation (ADDF).